Issued Patents All Time
Showing 1–25 of 29 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12203100 | Development of dengue virus vaccine components | Stephen S. Whitehead, Joseph E. Blaney, Brian R. Murphy | 2025-01-21 |
| 11753627 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | Stephen S. Whitehead, Brian R. Murphy, Lewis Markoff, Barry Falgout, Joseph E. Blaney +1 more | 2023-09-12 |
| 11746335 | Development of dengue virus vaccine components | Stephen S. Whitehead, Joseph E. Blaney, Brian R. Murphy | 2023-09-05 |
| 11332722 | Development of dengue virus vaccine components | Stephen S. Whitehead, Joseph E. Blaney, Brian R. Murphy | 2022-05-17 |
| 11318196 | Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein | Stephen S. Whitehead, Brian R. Murphy, Kathryn A. Hanley, Joseph E. Blaney | 2022-05-03 |
| 10837003 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-utr of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 | Stephen S. Whitehead, Brian R. Murphy, Lewis Markoff, Barry Falgout, Joseph E. Blaney +1 more | 2020-11-17 |
| 10724007 | Development of dengue virus vaccine components | Stephen S. Whitehead, Joseph E. Blaney, Brian R. Murphy | 2020-07-28 |
| 10500264 | Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses | Stephen S. Whitehead, Brian R. Murphy, Kathryn A. Hanley, Joseph E. Blaney | 2019-12-10 |
| 10160957 | Development of dengue virus vaccine components | Stephen S. Whitehead, Joseph E. Blaney, Brian R. Murphy | 2018-12-25 |
| RE46641 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | Stephen S. Whitehead, Brian R. Murphy, Lewis Markoff, Barry Falgout, Joseph E. Blaney +1 more | 2017-12-19 |
| RE46631 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | Stephen S. Whitehead, Brian R. Murphy, Lewis Markoff, Barry Falgout, Joseph E. Blaney +1 more | 2017-12-12 |
| 9783596 | Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use | Ana P. Goncalvez, Robert H. Purcell | 2017-10-10 |
| 9783787 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4 | Stephen S. Whitehead, Brian R. Murphy, Lewis Markoff, Barry Falgout, Joseph E. Blaney +1 more | 2017-10-10 |
| 9707287 | Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein | Stephen S. Whitehead, Brian R. Murphy, Kathryn A. Hanley, Joseph E. Blaney | 2017-07-18 |
| RE46042 | Development of dengue virus vaccine components | Stephen S. Whitehead, Joseph E. Blaney, Brian R. Murphy | 2016-06-28 |
| 9273121 | Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use | Ana P. Goncalvez, Robert H. Purcell | 2016-03-01 |
| 9090873 | Development of dengue virus vaccine components | Stephen S. Whitehead, Joseph E. Blaney, Brian R. Murphy | 2015-07-28 |
| RE45123 | Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis | Stephen S. Whitehead, Brian R. Murphy, Kathryn A. Hanley, Joseph E. Blaney | 2014-09-09 |
| RE45053 | Attenuated dengue virus comprising mutations in the NS3 gene | Stephen S. Whitehead, Brian R. Murphy, Kathryn A. Hanley, Joseph E. Blaney | 2014-07-29 |
| RE45016 | Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses | Stephen S. Whitehead, Brian R. Murphy, Kathryn A. Hanley, Joseph E. Blaney | 2014-07-15 |
| 8632782 | Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region | Stephen S. Whitehead, Brian R. Murphy, Kathryn A. Hanley, Joseph E. Blaney | 2014-01-21 |
| 8506961 | Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (JEV) and their use | Ana P. Goncalvez, Robert H. Purcell | 2013-08-13 |
| 8337854 | Monoclonal antibodies against dengue and other viruses with deletion in Fc region | Ana P. Goncalvez, Robert H. Purcell | 2012-12-25 |
| 8337853 | Monoclonal antibodies that bind or neutralize dengue virus | Robert H. Purcell | 2012-12-25 |
| 7622113 | Monoclonal antibodies that bind or neutralize dengue virus | Robert H. Purcell | 2009-11-24 |